Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:46 pm Sale |
2022-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Nantahala Capital Management, LLC | 975,705 1.400% |
-2,074,854 (-68.02%) |
Filing History |
| 2023-02-14 3:47 pm Purchase |
2022-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Avidity Partners Management LP | 6,718,142 9.700% |
1,474,123 (+28.11%) |
Filing History |
| 2023-02-14 12:12 pm Purchase |
2022-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Frazier Life Sciences Public Fund, L.P. | 3,708,838 5.400% |
936,776 (+33.79%) |
Filing History |
| 2023-02-14 11:53 am Sale |
2022-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
BIOTECHNOLOGY VALUE FUND L P | 1,451,197 2.100% |
-3,480,682 (-70.58%) |
Filing History |
| 2023-02-06 2:46 pm Purchase |
2022-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
STATE STREET CORP STT |
3,648,463 5.360% |
3,648,463 (New Position) |
Filing History |
| 2023-01-31 5:52 pm Purchase |
2022-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
BLACKROCK INC BLK |
4,352,032 6.400% |
662,138 (+17.94%) |
Filing History |
| 2023-01-10 09:23 am Purchase |
2022-12-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
WELLINGTON MANAGEMENT CO LLP | 7,983,442 11.720% |
6,384,676 (+399.35%) |
Filing History |
| 2022-03-04 5:02 pm Sale |
2022-02-25 | 13D | Syndax Pharmaceuticals, Inc. SNDX |
Access Industries Holdings LLC | 2,603,709 4.700% |
-78,678 (-2.93%) |
Filing History |
| 2022-02-14 1:12 pm Purchase |
2021-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
BIOTECHNOLOGY VALUE FUND L P | 4,931,879 8.900% |
1,221,190 (+32.91%) |
Filing History |
| 2022-02-14 08:34 am Purchase |
2021-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Nantahala Capital Management, LLC | 3,050,559 5.800% |
3,050,559 (New Position) |
Filing History |
| 2022-02-11 8:54 pm Purchase |
2021-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Avidity Partners Management LP | 5,244,019 9.900% |
494,019 (+10.40%) |
Filing History |
| 2022-02-10 10:49 am Sale |
2021-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
ADAGE CAPITAL PARTNERS GP LLC | 1,200,000 2.280% |
-1,500,000 (-55.56%) |
Filing History |
| 2022-02-07 4:41 pm Purchase |
2021-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
BLACKROCK INC BLK |
3,689,894 7.000% |
1,369,488 (+59.02%) |
Filing History |
| 2022-02-04 09:24 am Sale |
2021-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
WELLINGTON MANAGEMENT CO LLP | 1,598,766 3.040% |
-1,016,677 (-38.87%) |
Filing History |
| 2021-12-23 5:28 pm Purchase |
2021-12-20 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Frazier Life Sciences Public Fund, L.P. | 2,772,062 5.600% |
2,772,062 (New Position) |
Filing History |
| 2021-05-10 4:05 pm Purchase |
2021-04-28 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
ADAGE CAPITAL PARTNERS GP LLC | 2,700,000 5.600% |
1,450,000 (+116.00%) |
Filing History |
| 2021-05-03 3:15 pm Purchase |
2021-04-21 | 13D | Syndax Pharmaceuticals, Inc. SNDX |
Access Industries Holdings LLC | 2,682,387 5.560% |
544,187 (+25.45%) |
Filing History |
| 2021-04-20 4:34 pm Purchase |
2021-04-20 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Avidity Partners Management LP | 4,750,000 9.900% |
1,442,000 (+43.59%) |
Filing History |
| 2021-02-16 4:22 pm Sale |
2020-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Boxer Capital LLC | 2,358,005 4.990% |
-405,564 (-14.68%) |
Filing History |
| 2021-02-16 11:32 am Purchase |
2020-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Avidity Partners Management LP | 3,308,000 7.100% |
708,000 (+27.23%) |
Filing History |